Twist Bioscience Corp
NASDAQ:TWST

Watchlist Manager
Twist Bioscience Corp Logo
Twist Bioscience Corp
NASDAQ:TWST
Watchlist
Price: 48.12 USD 0.38% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Twist Bioscience Corp?
Write Note

Twist Bioscience Corp
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Twist Bioscience Corp
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Twist Bioscience Corp
NASDAQ:TWST
Other Long-Term Assets
$5.9m
CAGR 3-Years
-14%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Long-Term Assets
$8.3B
CAGR 3-Years
20%
CAGR 5-Years
44%
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Other Long-Term Assets
$7.2B
CAGR 3-Years
15%
CAGR 5-Years
10%
CAGR 10-Years
23%
Amgen Inc
NASDAQ:AMGN
Other Long-Term Assets
$10.4B
CAGR 3-Years
18%
CAGR 5-Years
43%
CAGR 10-Years
21%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Long-Term Assets
$3.2B
CAGR 3-Years
49%
CAGR 5-Years
17%
CAGR 10-Years
95%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Long-Term Assets
$4.1B
CAGR 3-Years
70%
CAGR 5-Years
34%
CAGR 10-Years
31%
No Stocks Found

Twist Bioscience Corp
Glance View

Market Cap
2.8B USD
Industry
Biotechnology

In the bustling world of biotechnology, Twist Bioscience Corp. has emerged as a trailblazer with its innovative approach to DNA synthesis technology. Founded on the premise of leveraging the power of synthetic DNA, Twist has unraveled the potential of precision engineering in genetics. The company operates with a unique silicon-based DNA synthesis platform, which allows for the rapid and cost-effective production of high-quality DNA. This cutting-edge technology facilitates advancements in various domains such as drug development, agricultural biology, and data storage. By addressing the ever-growing demand for synthesized DNA across these sectors, Twist positions itself at the intersection of technology and life sciences, offering a robust solution that fuels the DNA-driven innovations of tomorrow. At its core, Twist Bioscience generates revenue by providing its customers with a streamlined supply of custom DNA products, catering to researchers and businesses that require precise genetic sequences with high fidelity. This includes synthetic genes, oligonucleotide pools, and libraries used for CRISPR screening and other applications. The company has strategically diversified its offerings to include specialized DNA libraries and biopharmaceutical solutions, further extending its reach into therapeutic discovery and development. By aligning its business model with the needs of its clients, Twist ensures consistent growth by capitalizing on the expanding markets of biotechnology and synthetic biology, turning its pioneering technological capabilities into a profitable enterprise.

TWST Intrinsic Value
57.3 USD
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Twist Bioscience Corp's Other Long-Term Assets?
Other Long-Term Assets
5.9m USD

Based on the financial report for Sep 30, 2024, Twist Bioscience Corp's Other Long-Term Assets amounts to 5.9m USD.

What is Twist Bioscience Corp's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
6%

Over the last year, the Other Long-Term Assets growth was -30%. The average annual Other Long-Term Assets growth rates for Twist Bioscience Corp have been -14% over the past three years , 6% over the past five years .

Back to Top